type 2 diabetes mellitus
Explore 2 research publications tagged with this keyword
Publications Tagged with "type 2 diabetes mellitus"
2 publications found
2026
1 publicationSemaglutide: Pharmacology and Clinical Evidence in Cardiometabolic Therapy
Background: Type 2 diabetes mellitus and obesity frequently coexist and contribute to cardiovascular and renal complications. Semaglutide, a long-acting glucagon-like peptide-1 receptor agonist, has expanded incretin pharmacology beyond glucose lowering toward broader cardiometabolic therapy. Methods: This narrative review integrated pharmacological and clinical evidence on semaglutide. Priority was given to pivotal randomized controlled trials, cardiovascular and renal outcome trials, pharmacokinetic studies and clinically relevant follow-up studies from the SUSTAIN, PIONEER, STEP, SELECT and FLOW programmes. Results: Semaglutide enhances glucose-dependent insulin secretion, suppresses glucagon, reduces appetite and energy intake, and delays gastric emptying. Once-weekly subcutaneous and once-daily oral formulations produced clinically important reductions in glycated hemoglobin and body weight. Semaglutide reduced major adverse cardiovascular events in high-risk patients with type 2 diabetes, lowered cardiovascular events in patients with established cardiovascular disease and obesity without diabetes, and slowed chronic kidney disease progression in patients with diabetes and chronic kidney disease. Gastrointestinal adverse effects were the main tolerability limitation, and substantial weight regain occurred after treatment withdrawal. Conclusion: Semaglutide is an important cardiometabolic therapy; optimal use requires patient selection, gradual dose escalation, monitoring and long-term treatment planning.
2015
1 publicationTraditional Use of Medicinal Plants for the Treatment of Diabetes Mellitus in Basra
This study aimed to document traditional use of medicinal plants for the treatment of diabetes mellitus in Basra city, south-eastern of Iraq and to compare this information with current knowledge of plant medicine in Iraq and other Mediterranean countries, to preserve valuable information about the traditional plants used for treatment of type 2 diabetes mellitus and also to discover new treatment for diabetes. This study was conducted during the period from February to April, 2015. 199 diabetic patients aged between 20 and 80 years were included in this study, 117 patients were females and 82 were males. In addition, the relative importance of each medicinal plant species reported as use value (UV). This study reported the medicinal uses of 16 plants, species belonging to 16 families. The most commonly used plant species are Boswellia Carterii, Commiphora myrrha, Citrullus Colocynthis, Olea europaea and Trigonella foenum-graecum. Some plants are used for medicinal purposes both in Basra and in other parts of Mediterranean countries, either for the same or for different purposes. This paper helps to preserve valuable information about the traditional plants used for treatment of type 2 diabetes mellitus and also to discover new treatment for diabetes.
